Reproductive Medicine Associates of Southern California

Los Angeles, California 90064

Medical Director: Thomas Kim, MD

Reproductive Medicine Associates of Southern California, led by Medical Director Dr. Thomas Kim, provides comprehensive fertility care in Los Angeles with a focus on helping families achieve their dreams through advanced reproductive medicine. The clinic offers essential services including in vitro fertilization (IVF), egg freezing for fertility preservation, and surrogacy support, all delivered through their verified, accredited laboratory facilities.

What sets RMA of Southern California apart are their strong clinical outcomes, particularly for younger patients. Their live birth rates demonstrate consistent success: 56.50% for patients under 35 and 53.30% for those ages 35-37. Having completed 446 treatment cycles in 2022, the team brings both experience and proven results to each patient's unique journey. For those feeling overwhelmed by fertility treatment options, RMA of Southern California offers the combination of medical expertise, laboratory excellence, and track record of success that can provide confidence during this important chapter of building your family.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3556.50%+8.172.20%48.4%
35–3753.30%+17.355.20%36%
38–4036.40%+12.857.10%23.6%
Over 4020.70%+11.266.70%9.5%

Based on 446 total cycles reported. National averages computed across all reporting clinics.

Physicians

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.